Delamanid- A Relatively New Anti-Tuberculosis Drug

Journal Title: Journal of Contemporary Medicine and Dentistry - Year 2018, Vol 6, Issue 3

Abstract

Background: Tuberculosis (TB) is a global health problem which occurs in every part of the world. It is a curable and preventable bacterial infectious disease caused by Mycobacterium tuberculosis, still it is prevalent. Emergence of MDR and XDR-TB made the picture more complicated. Hence search for new drugs are going on to address the problem. Delamanid is a relatively new drug developed to tackle the situation. Methods: Medline database was searched using the keywords like Delamanid, Tuberculosis, New anti TB drugs, Multi drug resistant tuberculosis (MDR-TB), XDR-TB to find out the articles related with Delamanid. Results: The literature indicates that Delamanid is a good drug along with other appropriate anti TB drugs for the management of multi drug resistant tuberculosis. Conclusion: Delamanid in the dose of 100mg twice daily along with other appropriate anti TB drugs is recommended for the management of pulmonary multi drug resistant tuberculosis. It is relatively safe drug as have less adverse drug reactions and drug interactions.

Authors and Affiliations

Kishor A Bansod, Mohammed Shakeel Mohammed Bashir, Tanveer Khan

Keywords

Related Articles

A Review of Utility of Magnetic Resonance Imaging Compared to that of Arthroscopy in Diagnosis of Knee Ligamentous Injury

Orthopedic surgeons relied absolutely on clinical exam within the late 1960 & early 70’s till several reports advised the function of arthroscopy in prognosis and remedy of diverse knee disorders. Whilst comparing the ac...

Management of Knee Joint Osteoarthritis with Total Knee Arthroplasty

Background: Osteoarthritis is thought to be the most prevalent chronic joint disease. The incidence of osteoarthritis is rising because of the ageing population and the epidemic of obesity. Pain and loss of function are...

Platelet Indices in Pregnancy Induced Hypertension

Preeclampsia is a syndrome with both maternal and fetal manifestations. Haematological abnormalities such as thrombocytopenia and decrease in some plasma clotting factors may develop in pre-eclamptic women. The platelet...

Oral submucous fibrosis and iron deficiency anemia: A clinical study

Background: Oral submucous fibrosis (OSMF) is a potentially malignant disorder and crippling condition of oral mucosa. It is a well-recognized chronic insidious disease, precancerous condition, autoimmune and collagen re...

Gingival Pyogenic Granuloma – Case Report

Pyogenic Granuloma is an inflammatory hyperplastic soft tissue lesion of the skin and mucous membrane predominantly seen in young females primarily due to the hormonal changes during this period, expressed as a change in...

Download PDF file
  • EP ID EP454492
  • DOI -
  • Views 108
  • Downloads 0

How To Cite

Kishor A Bansod, Mohammed Shakeel Mohammed Bashir, Tanveer Khan (2018). Delamanid- A Relatively New Anti-Tuberculosis Drug. Journal of Contemporary Medicine and Dentistry, 6(3), 9-11. https://europub.co.uk/articles/-A-454492